Toxins
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. > Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: > Other > Other > Toxins
Duty Rate (from China)
Products classified under Tariff item 3002.49.00.20
Anthrax Vaccine Adsorbed (AVA)
Anthrax Vaccine Adsorbed (AVA), known as BioThrax, is a cell-free vaccine prepared from protective antigen of Bacillus anthracis adsorbed to aluminum hydroxide. It is used to induce immunity against anthrax in military personnel and emergency responders. This vaccine falls under tariff item 3002.49.00 as an 'other' vaccine derived from micro-organisms, not specifically named elsewhere in the subheading.
3002.49.00Chlamydia Vaccine (Recombinant)
This recombinant chlamydia vaccine uses the major outer membrane protein (MOMP) produced through biotechnological processes, combined with an adjuvant. It is designed to prevent trachoma and sexually transmitted chlamydial infections. As a vaccine obtained by biotechnological means, it is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Cholera Vaccine (Oral Recombinant)
Dukoral is an oral cholera vaccine containing inactivated Vibrio cholerae whole cells and recombinant cholera toxin B subunit. It provides mucosal immunity against cholera and is administered as an oral suspension with a buffer solution. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine, as it is not specifically named in other subheadings.
3002.49.00Dengue Vaccine (Tetravalent Live Attenuated)
Dengvaxia is a tetravalent live-attenuated vaccine against dengue fever, created using recombinant DNA technology with a yellow fever 17D backbone. It is indicated for individuals with prior dengue infection to prevent severe disease. As a vaccine obtained by biotechnological processes, it falls under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Inactivated Polio Vaccine (IPV)
Inactivated Polio Vaccine (IPV) contains killed poliovirus strains (types 1, 2, and 3) that stimulate protective immunity without causing disease. It is used in routine childhood immunization and booster doses. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine for prophylactic use in humans.
3002.49.00Japanese Encephalitis Vaccine (Inactivated)
Ixiaro is an inactivated Japanese encephalitis vaccine produced from Vero cell cultures, used for active immunization of adults and children traveling to endemic areas. It is a purified, inactivated whole-virus vaccine. This product falls under tariff item 3002.49.00 as an 'other' vaccine derived from micro-organisms.
3002.49.00Norovirus Vaccine (Virus-Like Particles)
This norovirus vaccine candidate uses virus-like particles (VLPs) produced by recombinant technology to mimic the viral capsid and induce immunity. It is designed to prevent acute gastroenteritis caused by norovirus. As a biotechnologically obtained vaccine, it is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Paratyphoid Vaccine (Oral Live Attenuated)
This oral live-attenuated vaccine uses Salmonella Paratyphi A bacteria to provide protection against paratyphoid fever, often combined with typhoid vaccines. It is administered orally in a multi-dose regimen. As a culture of micro-organisms used as a vaccine, it falls under tariff item 3002.49.00 as an 'other' product.
3002.49.00Q Fever Vaccine (Inactivated)
Q-Vax is an inactivated whole-cell vaccine prepared from Coxiella burnetii, used to protect individuals at high risk of Q fever, such as veterinarians and abattoir workers. It requires prior skin testing to identify sensitized individuals. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine from micro-organisms.
3002.49.00Rabies Vaccine for Human Use
This rabies vaccine is a purified, inactivated vaccine derived from the rabies virus grown in human diploid cell cultures. It is used for both pre-exposure prophylaxis and post-exposure treatment of rabies. As a vaccine for human use, it is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Ross River Virus Vaccine (Inactivated)
This inactivated Ross River virus vaccine is produced from purified viral particles and is intended to prevent Ross River fever, a mosquito-borne disease causing arthritis. It is administered as a two-dose primary series. As a vaccine derived from a virus, it falls under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Shigella Flexneri Vaccine (Oral Live)
FlexLev is a live-attenuated oral vaccine using Shigella flexneri 2a strain Sc4020 to protect against shigellosis, particularly for military personnel and travelers. It is delivered as a single-dose sachet for oral administration. As a culture of micro-organisms used as a vaccine, it is classified under tariff item 3002.49.00 as an 'other' product.
3002.49.00Tick-Borne Encephalitis Vaccine
FSME-Immun is an inactivated tick-borne encephalitis vaccine produced from the virus cultured in chick embryo cells. It is used to protect against tick-borne encephalitis in endemic regions of Europe and Asia. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine obtained by biotechnological processes.
3002.49.00Yellow Fever Vaccine (17D Strain)
This yellow fever vaccine uses the live-attenuated 17D strain grown in chick embryo cells to provide long-lasting immunity against yellow fever virus. It is required for travelers to endemic areas in Africa and South America. As a vaccine for human use, it falls under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Zika Virus Vaccine (DNA-Based)
This DNA-based Zika vaccine candidate uses a recombinant plasmid encoding the prM-E proteins of the Zika virus to induce neutralizing antibodies. It is an investigational vaccine for prevention of Zika virus infection. As a biotechnologically obtained vaccine, it is classified under tariff item 3002.49.00 as an 'other' vaccine.